- Home
- SBRA vs CAI Comparison
SBRA vs CAI Comparison
Compare SBRA & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$20.48
HOLD
Current Price
$15.41
Company Overview
Basic Information| Metric | SBRA | CAI |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.4B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBRA | CAI |
|---|---|---|
| Price | $20.48 | $15.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $22.00 | ★ $30.91 |
| AVG Volume (30 Days) | 1.8M | ★ 3.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | ★ 18.52 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $774,632,000.00 | N/A |
| Revenue This Year | $7.50 | $25.24 |
| Revenue Next Year | $9.07 | $22.32 |
| P/E Ratio | $130.31 | ★ N/A |
| Revenue Growth | ★ 10.15 | N/A |
| 52 Week Low | $17.13 | $14.19 |
| 52 Week High | $21.28 | $42.50 |
Technical Indicators
Market Signals| Indicator | SBRA | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 39.95 |
| Support Level | $18.24 | $14.19 |
| Resistance Level | $20.90 | $19.79 |
| Average True Range (ATR) | 0.33 | 1.03 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 22.71 | 20.55 |
Price Performance
Historical Comparison SBRA
CAI
About SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.